688510 Stock Overview
Manufactures aero-engines and medical orthopedic implant forging system integration components.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Wuxi Hyatech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥17.40 |
52 Week High | CN¥20.50 |
52 Week Low | CN¥10.21 |
Beta | 0.17 |
11 Month Change | 0.64% |
3 Month Change | -10.59% |
1 Year Change | -8.66% |
33 Year Change | -34.22% |
5 Year Change | n/a |
Change since IPO | -53.20% |
Recent News & Updates
Is Wuxi HyatechLtd (SHSE:688510) A Risky Investment?
Jun 26Wuxi HyatechLtd's (SHSE:688510) Solid Profits Have Weak Fundamentals
Apr 03Shareholder Returns
688510 | CN Aerospace & Defense | CN Market | |
---|---|---|---|
7D | -1.6% | 2.6% | -2.9% |
1Y | -8.7% | -15.5% | -20.9% |
Return vs Industry: 688510 exceeded the CN Aerospace & Defense industry which returned -15.5% over the past year.
Return vs Market: 688510 exceeded the CN Market which returned -20.9% over the past year.
Price Volatility
688510 volatility | |
---|---|
688510 Average Weekly Movement | 4.9% |
Aerospace & Defense Industry Average Movement | 6.6% |
Market Average Movement | 5.8% |
10% most volatile stocks in CN Market | 9.1% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 688510 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688510's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 619 | Hongda Zhu | www.hyatech.cn |
Wuxi Hyatech Co.,Ltd. manufactures aero-engines and medical orthopedic implant forging system integration components. The company offers aeroengine compressor blades, rotating, and structural parts.
Wuxi Hyatech Co.,Ltd. Fundamentals Summary
688510 fundamental statistics | |
---|---|
Market cap | CN¥4.72b |
Earnings (TTM) | CN¥123.43m |
Revenue (TTM) | CN¥627.47m |
36.4x
P/E Ratio7.2x
P/S RatioIs 688510 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688510 income statement (TTM) | |
---|---|
Revenue | CN¥627.47m |
Cost of Revenue | CN¥375.03m |
Gross Profit | CN¥252.43m |
Other Expenses | CN¥129.01m |
Earnings | CN¥123.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.48 |
Gross Margin | 40.23% |
Net Profit Margin | 19.67% |
Debt/Equity Ratio | 18.2% |
How did 688510 perform over the long term?
See historical performance and comparison